The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Fingolimod MSN 0.5 mg hard capsules



MSN Labs Europe LimitedPA23250/007/001

Main Information

Trade NameFingolimod MSN 0.5 mg hard capsules
Active SubstancesFingolimod
Dosage FormCapsule, hard
Licence HolderMSN Labs Europe Limited
Licence NumberPA23250/007/001

Group Information

ATC CodeL04AA27 fingolimod

Status

License statusAuthorised
Licence Issued27/11/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back